These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18362196)

  • 1. Interactions of DB75, a novel antimalarial agent, with other antimalarial drugs in vitro.
    Purfield AE; Tidwell RR; Meshnick SR
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2253-5. PubMed ID: 18362196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of piperaquine, chloroquine, and amodiaquine on drug uptake and of these in combination with dihydroartemisinin against drug-sensitive and -resistant Plasmodium falciparum strains.
    Fivelman QL; Adagu IS; Warhurst DC
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2265-7. PubMed ID: 17404003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum: in vitro interactions of artemisinin with amodiaquine, pyronaridine, and chloroquine.
    Gupta S; Thapar MM; Mariga ST; Wernsdorfer WH; Björkman A
    Exp Parasitol; 2002 Jan; 100(1):28-35. PubMed ID: 11971651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro.
    Canfield CJ; Pudney M; Gutteridge WE
    Exp Parasitol; 1995 May; 80(3):373-81. PubMed ID: 7729473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolone-N-oxide derivatives: in vitro activity against fresh clinical isolates of Plasmodium falciparum, stage specificity and in vitro interactions with established antimalarial drugs.
    Tahar R; Vivas L; Basco L; Thompson E; Ibrahim H; Boyer J; Nepveu F
    J Antimicrob Chemother; 2011 Nov; 66(11):2566-72. PubMed ID: 21862474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo.
    Vivas L; Rattray L; Stewart LB; Robinson BL; Fugmann B; Haynes RK; Peters W; Croft SL
    J Antimicrob Chemother; 2007 Apr; 59(4):658-65. PubMed ID: 17337512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic interactions of amodiaquine and its major metabolite desethylamodiaquine with artemisinin, quinine and atovaquone in Plasmodium falciparum in vitro.
    Mariga ST; Gil JP; Wernsdorfer WH; Björkman A
    Acta Trop; 2005 Mar; 93(3):221-31. PubMed ID: 15725382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.
    Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A
    Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of in vitro resistance to eleven standard or new antimalarial drugs among Plasmodium falciparum isolates from Pointe-Noire, Republic of the Congo.
    Pradines B; Hovette P; Fusai T; Atanda HL; Baret E; Cheval P; Mosnier J; Callec A; Cren J; Amalvict R; Gardair JP; Rogier C
    J Clin Microbiol; 2006 Jul; 44(7):2404-8. PubMed ID: 16825356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo properties of ellagic acid in malaria treatment.
    Soh PN; Witkowski B; Olagnier D; Nicolau ML; Garcia-Alvarez MC; Berry A; Benoit-Vical F
    Antimicrob Agents Chemother; 2009 Mar; 53(3):1100-6. PubMed ID: 19015354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro.
    Lütgendorf C; Rojanawatsirivet C; Wernsdorfer G; Sirichaisinthop J; Kollaritsch H; Wernsdorfer WH
    Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):70-6. PubMed ID: 17131244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A non-radiolabeled heme-GSH interaction test for the screening of antimalarial compounds.
    Garavito G; Monje MC; Maurel S; Valentin A; Nepveu F; Deharo E
    Exp Parasitol; 2007 Jul; 116(3):311-3. PubMed ID: 17336296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of
    Sharma S; Bharti RS; Bhardwaj N; Anvikar AR; Valecha N; Mishra N
    Indian J Med Microbiol; 2017; 35(4):485-490. PubMed ID: 29405138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro.
    Chawira AN; Warhurst DC
    J Trop Med Hyg; 1987 Feb; 90(1):1-8. PubMed ID: 3546715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.
    Co EM; Dennull RA; Reinbold DD; Waters NC; Johnson JD
    Antimicrob Agents Chemother; 2009 Jun; 53(6):2557-63. PubMed ID: 19349518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimalarial activity of new atovaquone derivatives.
    El Hage S; Ane M; Stigliani JL; Marjorie M; Vial H; Baziard-Mouysset G; Payard M
    Eur J Med Chem; 2009 Nov; 44(11):4778-82. PubMed ID: 19747753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum: Solanum nudum SN-1 steroid antiplasmodial activity when combined with antimalarial drugs.
    Pabón A; Deharo E; Blair S
    Exp Parasitol; 2011 Jan; 127(1):222-7. PubMed ID: 20736008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs.
    Pradines B; Tall A; Rogier C; Spiegel A; Mosnier J; Marrama L; Fusai T; Millet P; Panconi E; Trape JF; Parzy D
    Trop Med Int Health; 2002 Mar; 7(3):265-70. PubMed ID: 11903989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum In Vitro Resistance to Monodesethylamodiaquine, Dakar, Senegal, 2014.
    Fall B; Madamet M; Camara C; Amalvict R; Fall M; Nakoulima A; Diatta B; Diémé Y; Wade B; Pradines B
    Emerg Infect Dis; 2016 May; 22(5):841-5. PubMed ID: 27088703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro antimalarial properties of azithromycin-chloroquine combinations that include the resistance reversal agent amlodipine.
    Pereira MR; Henrich PP; Sidhu AB; Johnson D; Hardink J; Van Deusen J; Lin J; Gore K; O'Brien C; Wele M; Djimde A; Chandra R; Fidock DA
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3115-24. PubMed ID: 21464242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.